Press room

Find out our latest Provepharm Life Solutions news and press releases in this News Room.

If you need further information, follow us on LinkedIn and Tweeter @Provepharm Life Solutions and #Provepharm.

By signing up to add our RSS feed, you will automatically receive the latest updates from us.
Press contact : Sophie Magendie – Press Relations & Communication

+33 763 593 184 – sophie.magendie@provepharm.com

Contact us

Pharmacovigilance & Medical device vigilance (Adverse events)

You can contact our Pharmacovigilance Department (24/7) on +44 (0)1 442 891 049.

Please use this number only for urgent safety enquiries out of business hours

Please use this form for Vigilance and Medical Information inquiry only.
For any other business, please use the «Business Contact» form.

 

Nature of inquiry (required) :

 

The personal data collected are processed by PROVEPHARM LIFE SOLUTIONS in compliance with the Privacy Policy. The purpose is only to treat and respond to your request. Information requested with an asterisk is mandatory. In accordance with current regulations (European Union GDPR), you have the right to access, rectify, erase, limit and transfer your personal data, the right to set guidelines for post-mortem privacy protection and the right to appeal to a supervisory body.

*France : adverse events can also be reported on the ANSM (French health Agency) website, following this link

 

The personal data collected are processed by PROVEPHARM LIFE SOLUTIONS in compliance with the Privacy Policy. The purpose is only to treat and respond to your request. Information requested with an asterisk is mandatory. In accordance with current regulations (European Union GDPR), you have the right to access, rectify, erase, limit and transfer your personal data, the right to set guidelines for post-mortem privacy protection and the right to appeal to a supervisory body.